Please assess the completion status of the following clinical trial:

Trial Title: Effect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* self-declared white/Caucasian~* self-declared African-American~* active~* ambulatory~* no evidence of medical disease~Exclusion Criteria:~* alcohol use of 3 or more drinks per day~* HIV or hepatitis (B or C) infection~* isoniazid~* disulfiram~* phenobarbital~* phenytoin~* carbamazepine~* rifampicin~* valproic acid~* probenecid~* St. John's Wort

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: t

Study Arms:
- White subjects (Type: EXPERIMENTAL): 2 x 500 mg acetaminophen by mouth once
- Black subjects (Type: EXPERIMENTAL): 2 x 500 mg acetaminophen by mouth once

Based on this trial design, predict the completion outcome and termination type (if applicable).